Compare Xcel Energy Inc (XEL) vs DENTSPLY SIRONA Inc (XRAY) Price & Performance

XEL trades at $78.72, down 0.06% on the day, with a bearish technical signal from moving averages and neutral oscillators. The company reported mixed recent earnings, missing in Q3 and Q4 2025 but beating in Q1 2026. Revenue grew to $14.67B in 2025, with a net income margin of 14.14%. Analyst consensus is bullish with a $94.50 price target, and the company maintains a steady dividend, with a recent payout declared for July 2026.

The outlook for XEL is supported by strong analyst buy ratings and a significant capital expenditure plan targeting growth, but risks include regulatory pushback and high debt levels. The stock's current valuation near historical highs requires monitoring of earnings delivery against expectations, particularly the upcoming Q2 2026 results.

Dentsply Sirona (XRAY) trades at $13.65, down 2.91% on the day, with a mixed technical picture showing a bullish moving average signal but overbought RSI levels. Fundamentally, the company reported a net loss of $598 million for 2025, with negative profit margins and an elevated EV/EBITDA of 91.48, though revenue remains stable near $3.7 billion. Recent news includes the appointment of a new CFO and expanded U.S. distribution partnerships, while the upcoming Q2 2026 earnings call on August 6 is a key near-term catalyst.

The outlook remains challenging due to persistent losses and margin pressure, offset by strategic growth initiatives. Investment opportunities lie in the company's market leadership and digital dentistry expansion, but risks include high debt levels, competitive pressures, and the need for a successful turnaround. Analyst consensus is Hold with a price target of $13.33, indicating limited near-term upside from current levels.